Medication info
Irostar 20 mg Tablets (Rosuvastatin Calcium)

Irostar 20 mg Tablets (Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
IYun Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets (10 tablets/Alu-Alu × 3)
Approval status
Active

MFDS item code 201405101 · Approved 2014.10.31 · Insurance code 658603120

Summary

Main use
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
Who takes it
Adults · Children
Adult dose
5 mg once daily. The maintenance dose is 10 mg once daily, and may be increased up to a maximum of 20 mg once daily at intervals of 4 weeks or longer. Elderly: No dose adjustment is necessary. Patients with mild or moderate renal impairment: No dose adjustment is necessary. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20 mg of this drug to patients with moderate renal impairment. No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. Asian patients: The recommended starting dose is 5 mg. A dose of 40 mg is contraindicated. Patients predisposed to myopathy: The recommended starting dose is 5 mg. A dose of 40 mg of this drug is contraindicated in some of these patients.
Child dose
Ages 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. Maximum daily dose: 20 mg. There are no clinical data on doses greater than 20 mg in pediatric patients. The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Ingredients

Manufacturer
IYun Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease

  • Hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • combined hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerosis
  • dysbetalipoproteinemia
  • coronary heart disease
  • stroke
  • myocardial infarction
View approved original text

This medicine is used as an adjunct for patients with primary hypercholesterolemia, particularly heterozygous familial hypercholesterolemia and combined hyperlipidemia, when diet and exercise alone do not control the condition. It is also used in conjunction with diet in patients with homozygous familial hypercholesterolemia to enhance effectiveness. It helps lower total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, thereby delaying the progression of atherosclerosis. Additionally, it is used as an adjunct therapy for certain pediatric patients aged 10 to 17 years with familial hypercholesterolemia. Moreover, it can be used as an adjunct for patients with dysbetalipoproteinemia and is effective in reducing cardiovascular disease risks, helping to lower the risk of stroke, myocardial infarction, and vasculopathy after coronary artery surgery. In summary, this medication is used to improve various conditions related to hypercholesterolemia and to reduce the risk of cardiovascular disease.

How to take

Adult dose

5 mg once daily. The maintenance dose is 10 mg once daily, and may be increased up to a maximum of 20 mg once daily at intervals of 4 weeks or longer. Elderly: No dose adjustment is necessary. Patients with mild or moderate renal impairment: No dose adjustment is necessary. Do not administer to patients with severe renal impairment. Particular caution should be exercised when administering 20 mg of this drug to patients with moderate renal impairment. No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this drug to patients with active liver disease. Asian patients: The recommended starting dose is 5 mg. A dose of 40 mg is contraindicated. Patients predisposed to myopathy: The recommended starting dose is 5 mg. A dose of 40 mg of this drug is contraindicated in some of these patients.

Child dose

Ages 10 to 17 years: The usual dose range is 5 mg to 20 mg once daily. Maximum daily dose: 20 mg. There are no clinical data on doses greater than 20 mg in pediatric patients. The dose should be adjusted individually according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For example, patients who are allergic to this medicine, have severe liver dysfunction, have muscular diseases, or are taking certain medications should not take this drug. Women who are pregnant or breastfeeding, as well as women who may become pregnant, should consult their doctor before taking this medication. This medicine may affect liver function, so caution is needed for patients with a history of liver disease or heavy alcohol consumption. Symptoms such as muscle pain or weakness may occur; if these symptoms appear, healthcare professionals should be notified immediately. This medication can interact with other drugs, so it is important to inform healthcare professionals about any currently used medications, especially when used in conjunction with certain antibiotics, antifungals, and immunosuppressants. Regular blood tests are recommended as liver enzymes or muscle-related levels may rise during clinical evaluations. This medication should be avoided during pregnancy as it may pose risks to the fetus, and caution is required when breastfeeding as this drug may pass into breast milk. There is no specific antidote for overdose, so treatment should be symptomatic; patients might experience dizziness while on this medication, necessitating caution when driving or operating machinery. Finally, this drug contains lactose, so patients with lactose intolerance should consult before taking it.

Side effects

Allergic reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, drug-induced erythroderma, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is important to store it in a cool place below 30 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets (10 tablets/Alu-Alu × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.